Investor Presentaiton

Diversified Revenue contribution across Geographies (2/2)... Revenue Mix between Geographies METROPOLIS The Pathology Specialist Q3FY22 7% 7% 25% Total Revenue Q3FY23 7% 8% Q3FY22 Q3FY23 Revenue Excl. Covid PCR & Covid Allied tests 6% 7% 30% 51% 4% 51% 56% 5% 4% 6% 8% 31% 51% 4% North South East West International 30% ✓ Revenues in North & East combined has grown by ~29% for Q3FY23 on a Y-o-Y basis, indicating volume & realization growth in our Non-Core geographies ✓ Revenue in West has grown by 21% on a Y-o-Y basis, indicating our strength & brand equity in the core geographies Q3FY22 includes Hitech Diagnostics w.e.f 22nd Oct 2021 15

View entire presentation